肌细胞发育过程中间隙连接的变化

用石蜡切片、超薄切片和冰冻蚀刻技术研究了东方蝾螈胚胎肌细胞发育过程中间隙连接的变化。间隙连接最初出现于原肠后期的体节中胚层细胞中,到原肠末期,体节中胚层细胞间的间隙连接数量骤增,从神经板期到鼻窝出现期,间隙连接数量保持在一个相当高的水平,肌效应期后,其数量明显下降,直到肌细胞发育成熟,神经-肌肉连接充分发育,间隙连接才消失。间隙连接大小的变化与数量的变化表现为平行的现象。此外,细胞融合之前,正是间隙连接的数量和大小达到最高峰的时间。这些结果说明细胞通讯与胚胎肌细胞发育密切相关。对细胞通讯在细胞决定和分化以及细胞融合中的可能作用进行了讨论。     

应用两种方法诱导SH-SY5Y细胞分化的研究

目的：观察全反式维甲酸（ATRA）处理和ATRA与十四烷酰佛波醇乙酸酯（TPA）序贯处理（ATRA/TPA）对人类神经母细胞瘤细胞系SH-SY5Y细胞增殖抑制和形态分化的影响。方法：应用10μM ATRA处理6天和10μM ATRA处理3天继以80 nMTPA处理3天这两种方法使SH-SY5Y细胞分化;用倒置光学显微镜动态观察SH-SY5Y细胞形态学变化;并用MTT比色法比较两种分化方法对SH-SY5Y细胞的体外抗增殖作用。结果：ATRA处理和ATRA与TPA序贯处理对SH-SY5Y细胞都有抗增值和诱导细胞分化作用,细胞形态发生明显的变化,分化成神经元表型,前者主要表现为两端带有长突起的纺锤体样细胞形态,而后者主要是由细胞体延伸出多个突起的多边形的细胞。ATRA分化6天的细胞的存活率下降为78.7%±2.0%。当去除ATRA后,继续培养1天的细胞存活率上升为89%±0.2%,而继续培养2天的细胞存活率为86.3%±1.4%;ATRA与TPA序贯分化6天细胞存活率下降为75.9±0.4%。当去除TPA后,继续培养一天的细胞存活率为75.5±0.7%,继续培养2天的细胞存活率为74.9±1.0%。结论：维甲酸（ATRA）处理和ATRA与十四烷酰佛波醇乙酸酯（TPA）序贯处理（ATRA/TPA）均能明显诱导SH-SY5Y细胞分化。这两种分化细胞为神经科学的研究提供了优良的体外培养模型细胞,尤其是ATRA与TPA序贯处理能获得分化完全而稳定的神经元样细胞。     

小鼠胃粘膜细胞和人胃癌细胞间隙连接的超微结构研究与促癌变剂的影响

应用冷冻蚀刻电镜技术,我们观察到小鼠正常胃粘膜上皮细胞膜的间隙连接和紧密连接。人胃癌MGC-803细胞膜上未见到间隙连接和紧密连接,表明胃癌细胞间隙连接结构的消失是细胞连接通讯抑制的主要原因。促癌变剂TPA和黄芫花分别处理胃粘膜导致膜上皮细胞的间隙连接消失或明显减少。本结果支持关于细胞连接通讯抑制是胃癌癌变机理之一,可能与癌变的促进有关的分析。本文对细胞间隙连接数目变化快的现象及可能的调节机理进行讨论。     

应用两种方法诱导SH-SY5Y 细胞分化的研究

目的:观察全反式维甲酸(ATRA)处理和ATRA与十四烷酰佛波醇乙酸酯(TPA)序贯处理(ATRA/TPA)对人类神经母细胞瘤细胞系SH-SY5Y细胞增殖抑制和形态分化的影响。方法:应用10μM ATRA处理6天和10μM ATRA处理3天继以80 nMTPA处理3天这两种方法使SH-SY5Y细胞分化;用倒置光学显微镜动态观察SH-SY5Y细胞形态学变化;并用MTT比色法比较两种分化方法对SH-SY5Y细胞的体外抗增殖作用。结果:ATRA处理和ATRA与TPA序贯处理对SH-SY5Y细胞都有抗增值和诱导细胞分化作用,细胞形态发生明显的变化,分化成神经元表型,前者主要表现为两端带有长突起的纺锤体样细胞形态,而后者主要是由细胞体延伸出多个突起的多边形的细胞。ATRA分化6天的细胞的存活率下降为78.7%±2.0%。当去除ATRA后,继续培养1天的细胞存活率上升为89%±0.2%,而继续培养2天的细胞存活率为86.3%±1.4%;ATRA与TPA序贯分化6天细胞存活率下降为75.9±0.4%。当去除TPA后,继续培养一天的细胞存活率为75.5±0.7%,继续培养2天的细胞存活率为74.9±1.0%。结论:维甲酸(ATRA)处理和ATRA与十四烷酰佛波醇乙酸酯(TPA)序贯处理(ATRA/TPA)均能明显诱导SH-SY5Y细胞分化。这两种分化细胞为神经科学的研究提供了优良的体外培养模型细胞,尤其是ATRA与TPA序贯处理能获得分化完全而稳定的神经元样细胞。     

胃癌细胞与正常细胞的间隙连接通讯和促癌剂效应的研究

本文介绍用一种新的快速、简便SLDT’技术研究培养细胞的间隙连接通讯功能。细胞划痕后,标记两种荧光染料——Lucifer’Yellow(LY, MW.457.2)和Rhodamine Dextran(RD,MW.10,000)。RD停留原位,LY小分子传输到邻近细胞,表示间隙连接通讯现象。用SLDT方法观察到人胃腺癌MGC一803细胞无连接通讯功能。钙调素抑制剂T"FP有使胃癌细胞恢复连接通讯的效应。中国地鼠V,。细胞,wB大鼠肝细胞和鸡胚成肌细胞有通讯功能。促癌变剂TPA阻断正常细胞的间隙连接通讯,并阻断由。rFP丐导的胃癌细胞连接通讯。     

小鼠肌母细胞的增殖与分化

通过对小鼠肌母细胞C2C12的培养,研究C2C12细胞的增殖与分化的关系以及胰岛素在细胞分化过程中的作用。在对照组中,C2C12细胞增殖占了明显的优势,细胞形态几乎没有发生变化;而在实验组中,C2C12细胞在换为分化培养基24小时后,就出现了部分细胞衰亡和死亡的现象,尤其是在48小时细胞的死亡率达到最高,存活细胞开始从增殖期进入分化期,72小时出现了少量肌管,在96小时细胞分化效果达到最好。而在添加了胰岛素的分化培养基中的细胞分化效果明显好于没有添加胰岛素的分化培养基中的细胞,结果表明,胰岛素促进C2C12细胞的分化。     

癌细胞逆转过程中N-cadherin与间隙连接蛋白Cx43功能表达的关系

钙粘合蛋白 (N cadherin ,N cad)在人肺癌细胞的表达明显低于正常人肺细胞 .肺癌细胞的间隙连接通讯功能缺陷 ,连接蛋白Cx43表达抑制 .Cx43cDNA转染肺癌细胞的 4个阳性克隆其Cx43蛋白表达升高水平相近 ,但通讯功能有差别 ,与各克隆N cad的表达水平有正相关性 .N cad表达高的克隆Cx43在膜间隙连接的分布和通讯功能最明显 ,细胞分化改善 ,在裸鼠体内生长抑制 (抑制率 75 % )有显著性 .反之N cad表达低的克隆Cx43在膜间隙连接不明显 ,细胞通讯功能弱 ,恶性表型无逆转 .提示N cad与Cx43转录后表达过程的调节密切相关 ,两者介导的粘合和通讯功能有协同促进肺癌细胞逆转的作用 .     

肾小球系膜细胞间隙连接的通讯功能及其影响因素

本文利用激光扫描共聚焦显微镜及荧光漂白后荧光回复技术对人肾小球系膜细胞间隙连接的通讯功能及其影响因素进行了观察。结果发现,体外培养的肾小球系膜细胞在融合生长状况下,相邻两细胞有间隙连接结构形成。不同浓度的血管紧张素Ⅱ对肾小球系膜细胞间隙连接的通讯功能具有促进作用,而甲基强的松龙则具有抑制作用。     

间隙连接蛋白Cx43在人胚肺和肺癌细胞表达的研究

细胞与细胞之间通过细胞膜上的间隙连接通道交换小分子和离子进行细胞间通讯,对细胞增殖分化调控和机体内环境稳定有重要作用。用间隙连接蛋白Ｃｘ４３ｃＤＮＡ探针Ｎｏｒｔｈｅｒｎ印迹杂交,Ｃｘ４３抗体免疫荧光染色和罗氏黄荧光染料传输方法检查,正常人胚肺细胞的Ｃｘ４３在ｍＲＮＡ和蛋白水平有高表达,Ｃｘ４３蛋白免疫荧光分布在间隙连接的部位,细胞间隙连接通讯功能明显。与正常相反,人肺癌ＰＧ系细胞Ｃｋ４３无论在ｍＲＮＡ或蛋白质水平都无表达,细胞通讯功能缺陷。结果表明Ｃｘ４３在培养的人胚肺细胞有功能性表达。人肺癌ＰＧ细胞通讯功能缺陷与Ｃｘ４３基因转录抑制有关。对Ｃｘ基因的抑癌基因性质进行讨论。     

成纤维细胞对体外培养的骨胳肌细胞早期发育的影响

用无血清、无胚胎提取液的培养液培养由鸡胚腿肌制成的细胞悬液,在排除神经因素的条件下,研究成纤维细胞对体外培养的骨胳肌细胞早期发育的影响。实验组的培养液由2份培养过成纤维细胞的 Eagle's(MEM)液(条件培养液)和1份 Eagle's 液组成。对照组的培养液为 Eagle's 液。细胞悬液被稀释成7种密度(1×10~6—1×10~4细胞/ml)。所得结果如下;(1)成纤维细胞作为支架,肌母细胞在其上面分裂和融合。成纤维细胞的条件培养液维持肌细胞的存活,并促进其发育;(2)肌母细胞的融合与细胞密度有关。实验组肌母细胞融合所需的最低细胞密度是3×10~4细胞/ml,即30个细胞/mm~2,而对照组为3×10~5细胞/ml,即300个细胞/mm~2。实验结果提示,肌细胞早期发育可不依赖于神经因素,它能被胚眙肌肉中的成纤维细胞所促进。     

The effect of a phorbol ester on amphibian myogenesis

The effect of a phorbol ester (TPA) on myogenesis of urodelian embryo has been investigated. Presumptive somites were extirpated from mid-neurula, the stage when they have already attained certain degree of determination. The explants were treated with TPA (10 ng/ml in Steinberg solution with the addition of 10% Leibovitz's L-15) for 4 days, the period during which the frequency and size of gap junctions in normal myogenic cells are at the maximum. After the treatment many cells became dispersed and isolated while others spread out and remained connected in the form of a sheet. During further culture for 6 days in the solution without TPA myogenesis was blocked. Both the dispersed cells and the cells in a sheet remained at the earliest stage of muscle differentiation with irregular shape or in the form of myoblast, while cells of the control series formed myotubes containing bundles of myofibrils. The result suggests that the blockage of myogenesis is the consequence of interruption of junctional communication evoked by TPA treatment.     

Protein kinase C remains functionally active during TPA induced neuronal differentiation of SH-SY5Y human neuroblastoma cells.

SH-SY5Y human neuroblastoma cells can be induced to differentiate into a neuronal phenotype by treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA). In other cell systems, TPA treatment frequently leads to down-regulation of protein kinase C (PKC). However, we now report that TPA-treated and non-treated SH-SY5Y cells express PKC-alpha, but not PKC-beta and PKC-gamma, mRNA. Furthermore, only a slight down-regulation of the PKC-alpha protein could be seen during prolonged treatment with 16 nM TPA, the concentration giving optimal differentiation. In contrast, a higher concentration of TPA (1.6 microM) results in a poor neuronal differentiation and a complete down-regulation of PKC-alpha. PKC-alpha was rapidly translocated to the particulate fraction and remained membrane bound for at least 4 days during treatment with 16 nM TPA. In such cells a sustained increased level of the phosphorylated form of a 80,000 Dalton PKC-substrate was found. In addition to this sustained augmented phosphorylation, administration of fresh TPA at day 4 caused a small but reproducible further increased level of phosphorylated substrate. When the PKC activity was measured by the histone phosphorylation assay a substantial fraction of the initial enzyme activity could still be detected after 4 days of TPA treatment. Taken together, the data demonstrate that PKC remains functionally active during TPA induced differentiation of SH-SY5Y cells, which may suggest a continuous role for the enzyme during the differentiation process.     

The transient increase of tight junction permeability induced by bryostatin 1 correlates with rapid downregulation of protein kinase C-alpha

The role of PKC-alpha in altered epithelial barrier permeability following the activation of PKC by TPA (12-O-tetradecanoyl phorbol 13-acetate) and bryostatin 1 in LLC-PK1 cells was investigated in this study. Like TPA, bryostatin 1 binds to and activates PKC but unlike TPA, it is not a tumor promoter. TPA at 10(-7) M induced a sustained 95% decrease in transepithelial electrical resistance (R(t)) across LLC-PK1 epithelial cell sheets, while 10(-7) M bryostatin 1 caused only a 30% decrease in R(t), which spontaneously reversed after 5 h. Simultaneous exposure of cell sheets to 10(-7) M TPA and 10(-7) M bryostatin 1 blunted the increase in epithelial permeability observed with 10(-7) M TPA alone. Co-incubation of cell sheets with bryostatin 1 and MG-132, a proteasomal inhibitor, caused a further decrease in R(t) at the 6-h time point and inhibited the recovery in R(t) seen with bryostatin 1 alone at this time point. TPA caused a rapid translocation of PKC-alpha from the cytosol to the membrane of the cell where it remained elevated. Bryostatin 1 treatment resulted in a slower translocation of PKC-alpha from the cytosol to the membrane and a much more rapid downregulation of PKC-alpha, with disappearance from this compartment after only 6 h. The classical PKC inhibitor Go6976 prevented the decrease in R(t) seen with TPA. Treatment of cells with TPA and bryostatin 1 resulted in a PKC-alpha translocation and downregulation profile which more closely resembled that seen with bryostatin 1 alone. Co-incubation of cells with MG-132 and bryostatin 1 caused a slower downregulation of PKC-alpha from the membrane fraction. Bryostatin 1 treatment of cells expressing a dominant/negative form of PKC-alpha resulted in a slower and less extensive decrease in R(t) compared to the corresponding control cells. For both TPA and bryostatin 1, the level of PKC-alpha in the membrane-associated fraction of the treated cells correlated closely with increased transepithelial permeability. Due to its transient effect on tight junction permeability, bryostatin 1 offers a novel pharmacological tool to investigate junctional physiology.     

Effects of TPA, A23187, and prostaglandin F2 alpha on progesterone synthesis by dispersed ovine luteal cells

The possible roles of protein kinase C, intracellular calcium, and oxygen environment in luteal progesterone (P4) production and their interaction with prostaglandin (PGF2 alpha) were investigated in dispersed ovine luteal cells. The following experiments were performed: 1) dose response to TPA and A23187, 2) interactions between the phorbol ester TPA and PGF2 alpha at 5% or 18% O2, 3) effect of TPA and PGF2 alpha on basal and luteinizing hormone (LH)-stimulated P4 secretion, 4) interaction of submaximal inhibitory concentrations of TPA with PGF2 alpha and the effect of indomethacin (IN) on the TPA response. Day 9 (Day 0 = first day of estrus) corpora lutea (CL) from ewes exhibiting estrous cycles of normal duration (15-17 days) were dispersed and 50,000-150,000 cells were cultured for 4 h in Dulbecco's Modified Eagle Medium. The proportion of luteal cells greater than 22 microns in diameter in these preparations averaged 17.8 +/- 2.1%. P4 in medium and cells was measured by radioimmunoassay. Both TPA and A23187 inhibited basal P4 accumulation in a dose-dependent manner. Maximum inhibition (500 nM) by TPA was greater than by A23187 at the same concentration (66.4 +/- 3.4 and 83.2 +/- 7.2% of controls, respectively; p less than 0.05), and the two were not additive in their effects. Reducing O2 did not affect P4 accumulation with or without TPA, PGF2 alpha, or both. Basal P4 accumulation was inhibited 30% by TPA and 10% by PGF2 alpha, but no additivity was seen.(ABSTRACT TRUNCATED AT 250 WORDS)     

Quantitation of changes in cell surface determinants during skeletal muscle cell differentiation using monospecific antibody

The differentiation of skeletal muscle is characterized by recognition, alignment, and subsequent fusion of myoblast cells at their surfaces to form large, multinucleated myotubes. Monoclonal antibodies were used to investigate anti-genie changes in the cell surface membrane specific for various stages of myogenesis. Chick embryonic skeletal muscle cells were cultured in vitro to the desired stage of differentiation and then injected into BALB/c mice. Spleen cells from the immunized mice were hybridized with NS-1 or P3 8653 mouse myeloma cells. Hybrid cell clones were selected in HAT medium and screened using an indirect radioimmunoassay for the production of monoclonal antibodies specific to myogenic cell surfaces. Target cells for the radioimmunoassay included three stages of myogenesis (myoblasts, midfusion myoblasts, and myotubes) and chick lung cells as a control for polymorphic antigens. Sixty-one clones were obtained which produced antibodies specific for myogenic cells. Thirty-five of these clones were generated from mice immunized with midfusion myoblast stages of myogenesis and 26 were obtained from mice immunized with the later myotube stage of myogenesis. Quantitative measurements by RIA of myogenic determinants per cell surface area on each target cell type revealed that most of the determinants decrease during myogenesis when midfusion myoblasts are used as the immunogen. When myotube stages are used as the immunogen, more determinants increase with cell differentiation. Therefore, the most common pattern of determinant change is for them to be present at all stages of myogenesis but to vary quantitively through development. There are determinants unique to each stage of myogenesis and marked quantitative differences within a cell stage for each determinant.     

Effects of phorbol ester on GH, TSH and PRL release by superfused rat adenohypophysis

The present study was undertaken to examine the effects of 12-0-tetradecanoyl-phorbol-13-acetate (TPA), one of the potent tumor promoting agents, on GH, TSH and PRL release by rat adenohypophyseal dispersed cells and fragments, using a superfusion technique. TPA (10(-6) to 10(-5) M) stimulated GH release from acutely dispersed rat adenohypophyseal cells. Neither TSH nor PRL was affected, but both were increased by TRH in a dose-dependent fashion (10(-9) to 10(-7) M). In fragments, TPA (10(-8) to 10(-6) M) elicited a dose-related release of GH. Exposure of the fragments to 10(-6) M TPA for 5 min promptly caused a 5-fold increase in GH release which continued for at least 40 min after stopping the stimulation. The addition of somatostatin (SRIF) (10(-7) M) decreased basal GH release and abolished GH release induced by 10(-6) M TPA. In contrast to GH, neither TSH nor PRL release was affected by TPA, but both were stimulated by TRH. These results indicate 1) that GH release is more sensitive to stimulation with TPA in normal rat anterior pituitaries in vitro than the release of TSH and PRL, and 2) that SRIF abolishes TPA-induced GH release.     

PKC对小鼠受精卵发育的调控作用

为研究 TPA及 PKC的反义寡核苷酸对 1 -细胞期鼠受精卵发育的影响 ,采用免疫细胞化学法标记 PKC(α及 β亚型 ) ,并用激光扫描共聚焦显微镜测定卵内 PKC荧光强度 ;同时利用显微注射法注射 PKC的反义寡核苷酸 ,观察其对受精卵分裂的影响 . 1 0 0 μg/ L TPA对 1 -细胞期受精卵的发育具有完全抑制作用 .TPA处理 1 2 h后 ,对照组受精卵停留在 1 -细胞期 ,而未经 TPA处理的1 -细胞期卵可以分裂到 2 -细胞期 .共焦激光显示实验组与对照组相比 ,PKC(α、β亚型 )荧光强度均有下降 (P<0 .0 1 ) .显微注射 PKC antisenseα及 antisenseβ的受精卵 ,分别只有 1 4 .2 %和 3.33%的卵可以发育到 2 -细胞期 .与对照组 (注射 M2培养液 )差异显著 (P<0 .0 1 ) .结果表明 ,(1 ) TPA长期处理 1 -细胞期受精卵 ,抑制 1 -细胞期卵分裂到 2 -细胞期 ;(2 ) PKC的反义寡核苷酸 (α及β亚型 )可以抑制小鼠 1 -细胞期卵的发育     

Proliferation and liberation kinetics of the tissue polypeptide antigen of MCF-7 cells. Hormonal influence

The presence or absence of tissular polypeptide antigen (TPA) in the culture medium of hormone dependent breast cancer tumoral cells, the relationship between TPA concentration and cellular proliferative activity, have been investigated as well as whether TPA levels change in response to steroid preparations or the action of different antiestrogens. Results show that in MCF-7 cell line culture media, proteins antigenically related to TPA can be detected in concentrations which parallel the number of cells in culture. Consequently, TPA can be considered a cell proliferation marker. Hydroxy-tamoxifen at a concentration of 10(-7) M inhibited both cell proliferation and TPA antigen release, while the relative proportion between number of cells (valued by DNA quantification) and TPA concentration remained unchanged.     

Mitosis-specific phosphorylation of vimentin by protein kinase C coupled with reorganization of intracellular membranes

Using two types of anti-phosphopeptide antibodies which specifically recognize vimentin phosphorylated by protein kinase C (PKC) at two distinct PKC sites, we found that PKC acted as a mitotic vimentin kinase. Temporal change of vimentin phosphorylation by PKC differed form changes by cdc2 kinase. The mitosis-specific vimentin phosphorylation by PKC was dramatically enhanced by treatment with a PKC activator, 12-O-tetradecanoylphorbol-13-acetate (TPA), while no phosphorylation of vimentin by PKC was observed in interphase cells treated with TPA. By contrast, the disruption of subcellular compartmentalization of interphase cells led to vimentin phosphorylation by PKC. Cytoplasmic and nuclear membranes are fragmented and dispersed in the cytoplasm and some bind to vimentin during mitosis. Thus, targeting of activated PKC, coupled with the reorganization of intracellular membranes which contain phospholipids essential for activation, leads to the mitosis-specific phosphorylation of vimentin. We propose that during mitosis, PKC may phosphorylate an additional subset of proteins not phosphorylated in interphase.     

Phorbol esters inhibit chondrogenesis in limb mesenchyme by mechanisms independent of PGE2 or cyclic AMP1

Effects of the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) on chondrogenesis and concentrations of prostaglandin E2 (PGE2) and cyclic AMP (cAMP) were investigated in micromass cultures of chick limb mesenchyme derived from the distal tip of stage 25 limb buds. TPA completely inhibited chondrogenesis during the first 4 days of culture; however, a few small cartilage nodules formed by day 6. Relative to control cultures, both PGE2 and cAMP concentrations were altered by TPA treatment during the 6-day period of cell culture. Concentrations of both compounds increased in control cells during the first 24 h of culture and then declined during the remaining 5 days. In TPA-treated cells both PGE2 and cAMP levels increased progressively during the 6 days of days of cell culture, each being elevated at day 6 by twofold over control cells. The results suggest the presence of regulatory pathways important in chondrogenesis which occur independent of those initiated by PGE2 and the cAMP system.